Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 15792117)

1.

Expression analysis of cystatin C and M in laser-capture microdissectioned human breast cancer cells--a preliminary study.

Vigneswaran N, Wu J, Muller S, Zacharias W, Narendran S, Middleton L.

Pathol Res Pract. 2005;200(11-12):753-62.

PMID:
15792117
2.
3.

Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.

Trinkaus M, Vranic A, Dolenc VV, Lah TT.

Int J Biol Markers. 2005 Jan-Mar;20(1):50-9.

PMID:
15832773
4.

Cystatin m: a novel candidate tumor suppressor gene for breast cancer.

Zhang J, Shridhar R, Dai Q, Song J, Barlow SC, Yin L, Sloane BF, Miller FR, Meschonat C, Li BD, Abreo F, Keppler D.

Cancer Res. 2004 Oct 1;64(19):6957-64.

6.

Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.

Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D, Kurek R, Neubauer HJ.

Cancer Res. 2006 May 15;66(10):5278-86.

7.

The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.

Hildenbrand R, Schaaf A.

Int J Oncol. 2009 Jan;34(1):15-23.

PMID:
19082473
8.

Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression.

Ai L, Kim WJ, Kim TY, Fields CR, Massoll NA, Robertson KD, Brown KD.

Cancer Res. 2006 Aug 15;66(16):7899-909.

9.

Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.

Parker BS, Ciocca DR, Bidwell BN, Gago FE, Fanelli MA, George J, Slavin JL, Möller A, Steel R, Pouliot N, Eckhardt B, Henderson MA, Anderson RL.

J Pathol. 2008 Feb;214(3):337-46.

PMID:
17985332
10.

[Expression and clinical significance of KNSL4 in breast cancer].

Feng YM, Wan YF, Li XQ, Cao XC, Li X.

Ai Zheng. 2006 Jun;25(6):744-8. Chinese.

PMID:
16764773
11.
12.

Tumor-associated overexpression of the soluble T1-S receptor in lymph node-negative breast cancer.

Werenskiold AK, Prechtel D, Harbeck N, Höfler H.

Diagn Mol Pathol. 2000 Mar;9(1):26-34.

PMID:
10718210
13.

Nucleobindin 2 in human breast carcinoma as a potent prognostic factor.

Suzuki S, Takagi K, Miki Y, Onodera Y, Akahira J, Ebata A, Ishida T, Watanabe M, Sasano H, Suzuki T.

Cancer Sci. 2012 Jan;103(1):136-43. doi: 10.1111/j.1349-7006.2011.02119.x. Epub 2011 Nov 17.

PMID:
21988594
14.

Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.

Makdissi FB, Machado LV, Oliveira AG, Benvenuti TT, Katayama ML, Brentani MM, Osório CA, Mourão Netto M, Lyra EC, Carvalho F, Góes JC, Folgueira MA.

Braz J Med Biol Res. 2009 Dec;42(12):1128-37. Epub 2009 Nov 6.

15.

Expression of cathepsin B and cystatin C in human colorectal cancer.

Hirai K, Yokoyama M, Asano G, Tanaka S.

Hum Pathol. 1999 Jun;30(6):680-6.

PMID:
10374777
17.

Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.

Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, Hajduch M, Murray P, Kolar Z.

BMC Cancer. 2007 Mar 27;7:55.

18.

[Expression and clinical significance of LRP16 gene in human breast cancer].

Liao DX, Han WD, Zhao YL, Pu YD, Mu YM, Luo CH, Li XH.

Ai Zheng. 2006 Jul;25(7):866-70. Chinese.

PMID:
16831279
19.

Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer.

Dahl E, Kristiansen G, Gottlob K, Klaman I, Ebner E, Hinzmann B, Hermann K, Pilarsky C, Dürst M, Klinkhammer-Schalke M, Blaszyk H, Knuechel R, Hartmann A, Rosenthal A, Wild PJ.

Clin Cancer Res. 2006 Jul 1;12(13):3950-60.

20.

Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas.

Zhou W, Jiang Z, Liu N, Xu F, Wen P, Liu Y, Zhong W, Song X, Chang X, Zhang X, Wei G, Yu J.

J Cancer Res Clin Oncol. 2009 Jan;135(1):91-102. doi: 10.1007/s00432-008-0435-x. Epub 2008 Aug 1.

PMID:
18670789
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk